RE:Shareholders certainly can't complain that Dr.Crossley I think we all know what she is going to talk about, being here long enough. These are my talking points for her 1. Onboarding accelerating, 40k patients by end of 2021 2. 2mm monthly run rate exiting December 2021, 24mm for FY 2022, 36mm for CY 2022 3.nazdaq uplisting in 2022, no reverse split 4. Over 200k patients in backlog, will be all onboard within 18 to 24 months - sure yes, still 200k backlog after talking about it for 6 months 5. September 2021 q was the first q profitable 6. 11mm revenue for calendar year 2021 - - oh that is dead, so let's not talk about it 7. Minimum dilution from June 2021 - - oh what? That is not true? let's forget about it 8. We are after big clients, you will hear from us soon 9. We have no competition. I think that is about all?